We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
-6.94%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$33.6B
AUM Growth
-$4.11B
Cap. Flow
-$868M
Cap. Flow %
-2.58%
Top 10 Hldgs %
23.36%
Holding
1,444
New
70
Increased
662
Reduced
591
Closed
59

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$174M
2
AMAT icon
Applied Materials
AMAT
+$106M
3
FTNT icon
Fortinet
FTNT
+$93.1M
4
CMCSA icon
Comcast
CMCSA
+$92.9M
5
VAL icon
Valaris
VAL
+$91.2M

Top Sells

Rank Stock Value
1
K
Kellanova
K
+$115M
2
SLB icon
SLB Ltd
SLB
+$106M
3
CPB icon
Campbell Soup
CPB
+$105M
4
MRK icon
Merck
MRK
+$105M
5
STZ icon
Constellation Brands
STZ
+$100M

Sector Composition

Rank Sector Weight
1 Materials 33.63%
2 Technology 27%
3 Energy 8.42%
4 Healthcare 7.19%
5 Financials 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPMC
1276
DELISTED
Blueprint Medicines
BPMC
$43K ﹤0.01%
+652
New +$41.9K
INN
1277
Summit Hotel Properties
INN
$749M
$41K ﹤0.01%
6,038
-3,463
-36% -$27.1K
AHRT
1278
AH Realty Trust
AHRT
$527M
$40K ﹤0.01%
3,868
-2,219
-36% -$29K
TNDM icon
1279
Tandem Diabetes Care
TNDM
$1.38B
$40K ﹤0.01%
+831
New +$45.6K
DNA icon
1280
Ginkgo Bioworks
DNA
$584M
$39K ﹤0.01%
319
+163
+104% +$19.4K
OPI
1281
DELISTED
Office Properties Income Trust
OPI
$39K ﹤0.01%
2,763
-1,584
-36% -$29.7K
AVO icon
1282
Mission Produce
AVO
$1.13B
$38K ﹤0.01%
2,629
-670
-20% -$10.2K
BEP icon
1283
Brookfield Renewable
BEP
$10.2B
$38K ﹤0.01%
1,200
TXG icon
1284
10x Genomics
TXG
$5.97B
$38K ﹤0.01%
1,325
-86,854
-98% -$3.31M
ONEM
1285
DELISTED
1Life Healthcare
ONEM
$38K ﹤0.01%
+2,213
New +$34.7K
RPT
1286
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$37K ﹤0.01%
4,870
-2,702
-36% -$26.6K
ABCM
1287
DELISTED
Abcam PLC
ABCM
$37K ﹤0.01%
+2,501
New +$37.5K
XRAY icon
1288
Dentsply Sirona
XRAY
$2.83B
$36K ﹤0.01%
1,274
+134
+12% +$4.58K
AVD icon
1289
American Vanguard Corp
AVD
$70.4M
$35K ﹤0.01%
1,858
-354
-16% -$7.38K
BGDE
1290
Big Digital Energy Inc
BGDE
$33.1M
$35K ﹤0.01%
682
-3,656
-84% -$352K
BEAM icon
1291
Beam Therapeutics
BEAM
$2.67B
$34K ﹤0.01%
+716
New +$40.8K
LKFT
1292
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
$33K ﹤0.01%
+768
New +$39.4K
SNDL icon
1293
Sundial Growers
SNDL
$320M
$33K ﹤0.01%
15,268
-1,322
-8% -$3.69K
TSAT icon
1294
Telesat
TSAT
$611M
$33K ﹤0.01%
4,202
+3,320
+376% +$36.7K
SAFE
1295
DELISTED
Safehold Inc.
SAFE
$33K ﹤0.01%
1,252
-717
-36% -$27.9K
UHT
1296
Universal Health Realty Income Trust
UHT
$592M
$32K ﹤0.01%
739
-423
-36% -$21.6K
TWI icon
1297
Titan International
TWI
$466M
$31K ﹤0.01%
2,535
CNS icon
1298
Cohen & Steers
CNS
$4.35B
$30K ﹤0.01%
481
+193
+67% +$13.8K
SLVM icon
1299
Sylvamo
SLVM
$1.52B
$30K ﹤0.01%
882
-152
-15% -$5.77K
FELE icon
1300
Franklin Electric
FELE
$4.73B
$29K ﹤0.01%
353
-156
-31% -$13.3K

Similar funds

VanEck Associates's Q3 2022 Portfolio in Review

As of Q3 2022, VanEck Associates held 1,444 positions worth $33.6B, down 11% from $37.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

VanEck Associates's Q3 2022 filing shows 70 new, 662 increased, 591 reduced and 59 closed positions. Its largest new stake was Valaris: 1,902,492 shares worth $93.1M. The largest sale was Kellanova, an estimated $115M.

By sector, the portfolio is most concentrated in Materials at 34% of assets, down from 34% a quarter earlier, followed by Technology and Energy.

  • VanEck Associates's largest Q3 2022 buy was Valaris: 1,902,492 shares worth $93.1M.
  • VanEck Associates added most to NVIDIA in Q3 2022, an estimated $174M increase.
  • VanEck Associates's biggest Q3 2022 reduction was Kellanova, cutting an estimated $115M.
  • VanEck Associates fully exited CoStar Group in Q3 2022, selling an estimated $86.7M.
  • VanEck Associates's ten largest holdings make up 23% of its $33.6B portfolio in Q3 2022.
  • VanEck Associates opened 70 new positions and closed 59 in Q3 2022.
  • VanEck Associates's portfolio value fell 11% quarter-over-quarter to $33.6B.

Based on VanEck Associates's 13F filing for Q3 2022, filed 27 Oct 2022.